Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs

Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment - ScienceDirect

Frontiers Prophylactic alpha blockers fail to prevent postoperative urinary retention following orthopaedic procedures: evidence from a meta-analysis and trial sequential analysis of comparative studies

Frontiers in Pharmacology

PDF) Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers

Frontiers Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service

pediatric acute lymphoblastic leukemia - List of Frontiers' open access articles

Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients

Frontiers Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces

Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics

Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia